tamatinib
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Tyrosine-protein kinase SYKINHIBITOR
SYK inhibitor
Active metabolite of prodrug R-788 (Fostamatinib)
Chemistry & pharmacology
Loading structure…
SMILES
COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC- Mol. weight
- 470.46 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL475251 ↗
Also known as
- r-406
- r-406
- tamatinib
- tamatinib